Julia L Marcus
Overview
Explore the profile of Julia L Marcus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
2760
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eichenwald C, Higashi R, Hogan T, Naeem J, Marcus J, Krakower D, et al.
AJPM Focus
. 2025 Mar;
4(2):100311.
PMID: 40061154
Introduction: Implementing HIV pre-exposure prophylaxis in the U.S. is critical to decreasing HIV transmission. However, regional disparities in pre-exposure prophylaxis use exist, with the southern U.S. having the lowest uptake...
2.
Marcus J, Weddle A, Kelley C, Agwu A, Montalvo S, Sherman E, et al.
Clin Infect Dis
. 2025 Jan;
PMID: 39873495
Long-acting injectables (LAIs) for HIV prevention and treatment could dramatically improve health outcomes and health equity for people with HIV and those who could benefit from pre-exposure prophylaxis. Despite widespread...
3.
Traeger M, Leyden W, Volk J, Silverberg M, Horberg M, Davis T, et al.
JAMA Intern Med
. 2025 Jan;
185(3):273-281.
PMID: 39761062
Importance: Doxycycline postexposure prophylaxis (doxyPEP) has been shown to decrease the incidence of bacterial sexually transmitted infections (STIs) among people assigned male sex at birth in clinical trials, but data...
4.
5.
Junejo M, Marcus J, Katz K
JAMA Dermatol
. 2024 Nov;
161(1):7-8.
PMID: 39535772
No abstract available.
6.
Lee K, Sarovar V, Lam J, Leyden W, Alexeeff S, Lea A, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Sep;
33(12):1698-1705.
PMID: 39269284
Background: With extended lifespans for people with human immunodeficiency virus (PWH), there is a corresponding increased burden of chronic illnesses, including cancer. Our objective was to estimate the excess mortality...
7.
Traeger M, Krakower D, Mayer K, Jenness S, Marcus J
Sex Transm Dis
. 2024 Aug;
51(12):763-771.
PMID: 39115204
Background: Doxycycline used as postexposure prophylaxis (doxyPEP) within 72 hours of sex reduces the risk of bacterial sexually transmitted infections (STIs) in people assigned male sex at birth. Little is...
8.
Grobman B, Silverberg M, Marcus J
J Insur Med
. 2024 May;
51(1):25-28.
PMID: 38802086
Antiretroviral medications have substantially improved life expectancy for people with HIV. These medications are also highly effective in preventing HIV acquisition in people who do not have HIV, a strategy...
9.
Volk J, Leyden W, Lea A, Lee C, Donnelly M, Krakower D, et al.
J Acquir Immune Defic Syndr
. 2024 Feb;
95(4):362-369.
PMID: 38412047
Background: Preexposure prophylaxis (PrEP) use remains limited and inequitable, and strategies are needed to improve PrEP provision in primary care. Methods: We conducted a cluster randomized trial at Kaiser Permanente,...
10.
Lam J, Leyden W, Alexeeff S, Lea A, Hechter R, Hu H, et al.
Open Forum Infect Dis
. 2024 Feb;
11(2):ofad611.
PMID: 38323078
Background: Excess weight gain is an important health concern among people with HIV (PWH) on antiretroviral therapy (ART). The extent to which ART contributes to body mass index (BMI) changes...